Articles dans des revues avec comité de lecture (3)
1.
Devos, M., Diaz Vidal, P., Bouziotis, J., Anckaert, E., Dolmans, M.-M., & Demeestere, I. (2023). Impact of first chemotherapy exposure on follicle activation and survival in human cryopreserved ovarian tissue. Human reproduction, 38(3), 408-420. doi:10.1093/humrep/dead0132.
Ntemou, E., Diaz Vidal, P., Alexandri, C., Van Den Steen, G., Lambertini, M., & Demeestere, I. (2022). Ovarian toxicity of carboplatin and paclitaxel in mouse carriers of mutation in BRIP1 tumor suppressor gene. Scientific reports, 12(1), 1658. doi:10.1038/s41598-022-05357-x3.
Kteily, K., Pening, D., Diaz Vidal, P., Devos, M., Dechene, J., Op De Beeck, A., Botteaux, A., Janssens, S., Van den Abbeel, E., Goldrat, O., Delbaere, A., & Demeestere, I. (2021). Risk of contamination of semen, vaginal secretions, follicular fluid and ovarian medulla with SARS-CoV-2 in patients undergoing ART. Human reproduction. doi:10.1093/humrep/deab255 Participations à des congrès et colloques internationaux (8)
1.
Dias Nunes, J., Ntemou, E., Van Den Steen, G., Diaz Vidal, P., Devos, M., & Demeestere, I. (2023). In vitro and in vivo toxicity of carboplatin and paclitaxel . regimen on BRCA-mutated ovarian tissue fragments. Poster présenté à la conférence ESHRE annual meeting, 39th, Copenhagen, 25-28 June 2023.2.
Devos, M., Diaz Vidal, P., Anckaert, E., Dolmans, M.-M., & Demeestere, I. (2022). Impact of patient characteristics at ovarian tissue cryopreservation on follicle activation and survival. Poster présenté à la conférence ESHRE annual meeting (38th: 3-6/07/2022: Milan, Italy).3.
Devos, M., Diaz Vidal, P., Anckaert, E., Dolmans, M.-M., & Demeestere, I. (2021). Impact of chemotherapy prior to ovarian tissue cryopreservation on primordial follicles in pre-pubertal and young adult patients: Best International Abstract. Abstract session presented at Society for the Study of Reproduction (SSR) annual meeting(54th: 15-18 December 2021: St. Louis, USA)